The first AI-powered cardiovascular screening technology using retinal imaging can deliver the risk of a patient’s cardiovascular disease in three minutes.
Heart Eye is to launch Dr.Noon CVD, the first AI-powered cardiovascular screening technology using retinal imaging, which can deliver the risk of a patient’s cardiovascular disease in three minutes.
By analysing retinal vessel images with advanced artificial intelligence, the system autonomously predicts future cardiovascular risks, providing real-time scores without blood sampling or radiation.
“Cardiovascular disease is one of the biggest health challenges we face today,” said company director Husain Khaki.
“This AI solution is a real breakthrough, making it easier for people to get an early, accurate diagnosis without any invasive procedures,” he continued adding that the speed of the results was “a game-changer” for opticians, hospitals, and primary care providers.
Dr.Noon CVD is the first retinal-based AI tool capable of assessing cardiovascular risk with the same accuracy as heart CT scans. Patients avoid blood tests and radiation exposure, while clinicians receive accurate results in minutes. Plans are to develop the technology to perform non-invasive assessments for other organs.
Dr.Noon CVD will be launched at 100% Optical at London’s ExCeL at the beginning of March and at Optix Conference at The Celtic Manor in mid-March.
